Sitagliptin phosphate monohydrate / metformin hydrochloride

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus (Type 2)

Manufacturer:

Merck Frosst Canada Ltd.

Brand Name:

Janumet

Project Line:

Reimbursement Review

Project Number:

SR0182-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes mellitus (Type 2)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

June 23, 2010

Last Updated : March 22, 2024